TGF-β has paradoxical and context dependent effects on proliferation and anoikis in human colorectal cancer cell lines

References

• Alazzouzi H, Alhopuro P, Salovaara R, Sammalkorpi H, Jarvinen H, Mecklin J-P, Hemminki A, Schwartz S, Jr., Aaltonen LA, Arango D. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res 2005; 11(7)2606–2611
   Web of Science ®Google Scholar
• Alhopuro P, Alazzouzi H, Sammalkorpi H, Davalos V, Salovaara R, Hemminki A, Jarvinen H, Mecklin JP, Schwartz S, Jr., Aaltonen LA, et al. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res 2005; 11(17)6311–6316
   Google Scholar
• Biswas S, Chytil A, Washington K, Romero-Gallo J, Gorska AE, Wirth PS, Gautam S, Moses HL, Grady WM. Transforming growth factor b receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res 2004; 64(14)4687–4692
   Google Scholar
• Boisvert-Adamo K, Aplin AE. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis. Oncogene 2006; 25(35)4848–4856
   Google Scholar
• Boulay JL, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L, Laffer U, Herrmann R, Rochlitz C. SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 2002; 87(6)630–634
   PubMed Web of Science ®Google Scholar
• Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 2001; 29(2)117–129
   PubMed Web of Science ®Google Scholar
• Douma S, VanLaar T, Zevenhoven J, Meuwissen R, VanGarderen E, Peeper D. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430(7003)1034–1039
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene 2004a; 23(2)465–473
   PubMed Web of Science ®Google Scholar
• Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 2004b; 135(5)555–562
   PubMed Web of Science ®Google Scholar
• Elliott RL, Blobe GC. Role of transforming growth factor beta in human cancer. J Clin Oncol 2005; 23(9)2078–2093
   PubMed Web of Science ®Google Scholar
• Engle S, Hoying J, Boivin G, Ormsby I, Gartside P, Doetschman T. Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage in tumorigenesis. Cancer Res 1999; 59: 3379–3386
   PubMed Web of Science ®Google Scholar
• Engle SJ, Ormsby I, Pawlowski S, Boivin GP, Croft J, Balish E, Doetschman T. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 2002; 62(22)6362–6366
   PubMed Web of Science ®Google Scholar
• Eppert K, Scherer S, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis I, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal cancer. Cell 1996; 86: 543–552
   PubMed Web of Science ®Google Scholar
• Fernandez Y, Gu B, Martinez A, Torregrosa A, Sierra A. Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state. Int J Cancer 2002; 101(4)317–326
   Google Scholar
• Frisch SM, Francis H. Disruption of epithelial cell–matrix interactions induces apoptosis. J Cell Biol 1994; 124(4)619–626
   PubMed Web of Science ®Google Scholar
• Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13(5)555–562
   PubMed Web of Science ®Google Scholar
• Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 2003; 163(4)1539–1549
   PubMed Web of Science ®Google Scholar
• Gorska AE, Joseph H, Derynck R, Moses HL, Serra R. Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 1998; 9(3)229–238
   Google Scholar
• Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD, Neumann A, Brattain MG, Chang J, Kim S-J, et al. Mutational inactivation of transforming growth factor-beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59(2)320–324
   PubMed Web of Science ®Google Scholar
• Grossmann J. Molecular mechanisms of “detachment-induced apoptosis–Anoikis”. Apoptosis 2002; 7(3)247–260
   PubMed Web of Science ®Google Scholar
• Hahn S, Schutte M, Shamsul Hoque A, Moskaluk C, da Costa L, Rozenblum E, Weinstein C, Fischer A, Yeo C, Hruban R, et al. DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science 1996; 271: 350–353
   PubMed Web of Science ®Google Scholar
• Jung B, Smith E, Doctolero R, Gervaz P, Alonso J, Miyai K, Keku T, Sandler R, Carethers J. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers. Int J Cancer 2006; 118(10)2509–2513
   Google Scholar
• Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. Embo J 1997; 16(10)2783–2793
   PubMed Web of Science ®Google Scholar
• Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, Boland CR. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation [published erratum appears in Cancer Res 1995 Jan 1;55(1):201]. Cancer Res 1995; 54(16)4308–4312
   Google Scholar
• Lallemand F, Mazars A, Prunier C, Bertrand F, Kornprost M, Gallea S, Roman-Roman S, Cherqui G, Atfi A. Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 2001; 20(7)879–884
   Google Scholar
• Massague J. TGF-β signal transduction. Annu Rev Biochem 1998; 67(1)753–791
   PubMedGoogle Scholar
• Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, Moody SE, Chodosh LA, Arteaga CL. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res 2004; 64(24)9002–9011
   Google Scholar
• Normanno N, De Luca A, Maiello MR, Bianco C, Mancino M, Strizzi L, Arra C, Ciardiello F, Agrawal S, Salomon DS. CRIPTO-1: A novel target for therapeutic intervention in human carcinoma. Int J Oncol 2004; 25(4)1013–1020
   PubMedGoogle Scholar
• Oft M, Heider KH, Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 1998; 8(23)1243–1252
   PubMed Web of Science ®Google Scholar
• Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995; 55(23)5548–5550
   PubMed Web of Science ®Google Scholar
• Pierce D, Gorska A, Chytil A, Meise K, Page D, Coffey R, Moses H. Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc Natl Acad Sci USA 1995; 92: 4254–4258
   PubMed Web of Science ®Google Scholar
• Prehn JHM, Bindokas VP, Marcuccilli CJ, Krajewski S, Reed JC, Miller RJ. Regulation of neuronal Bc12 protein expression and calcium homeostasis by transforming growth factor type {beta} confers wide-ranging protection on rat hippocampal neurons. PNAS 1994; 91(26)12599–12603
   Google Scholar
• Ramachandra M, Atencio I, Rahman A, Vaillancourt M, Zou A, Avanzini J, Wills K, Bookstein R, Shabram P. Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis. Cancer Res 2002; 62(21)6045–6051
   Google Scholar
• Samowitz WS, Curtin K, Neuhausen S, Schaffer D, Slattery ML. Prognostic implications of BAX and TGFBRII mutations in colon cancers with microsatellite instability. Genes Chromosomes Cancer 2002; 35(4)368–371
   Google Scholar
• Sanchez-Capelo A. Dual role for TGF-[beta]1 in apoptosis. Cytokine Growth Factor Rev 2005; 16(1)15–34
   PubMed Web of Science ®Google Scholar
• Schlapbach R, Spanaus KS, Malipiero U, Lens S, Tasinato A, Tschopp J, Fontana A. TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur J Immunol 2000; 30(12)3680–3688
   Google Scholar
• Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 2001; 15(8)981–994
   Google Scholar
• Schutte M, Hruban R, Hedrick L, Cho K, Nadasdy G, Weinstein C, Bova G, Isaacs W, Cairns P, Nawroz H, et al. DPC4 gene in various tumor types. Cancer Res 1996; 56: 2527–2530
   PubMed Web of Science ®Google Scholar
• Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. Oncogene 2007; 26(23)3311–3320
   Google Scholar
• Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL. Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell 2001; 12(11)3328–3339
   Google Scholar
• Siegel P, Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 2003; 3(11)807–821
   PubMed Web of Science ®Google Scholar
• Swift LL, Farkas MH, Major AS, Valyi-Nagy K, Linton MF, Fazio S. A recycling pathway for resecretion of internalized apolipoprotein E in liver cells. J Biol Chem 2001; 276(25)22965–22970
   Google Scholar
• Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin M, Taketo M. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998; 92: 645–656
   PubMed Web of Science ®Google Scholar
• Watanabe T, Wu T-T, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001; 344(16)1196–1206
   PubMed Web of Science ®Google Scholar
• Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC, Imai K. Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 1998; 16(20)2681–2686
   PubMed Web of Science ®Google Scholar
• Zhu Y, Richardson J, Parada L, Graff J. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998; 94: 703–714
   PubMed Web of Science ®Google Scholar
• Zhu Z, Sanchez-Sweatman O, Huang X, Wiltrout R, Khokha R, Zhao Q, Gorelik E. Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 2001; 61(4)1707–1716
   Google Scholar